Risks in a Trial of an Innovative Treatment of Duchenne Muscular Dystrophy

Pediatrics - United States
doi 10.1542/peds.2015-1589
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Academy of Pediatrics (AAP)

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy